MaxCyte (MXCT) Competitors GBX 1.62 0.00 (0.00%) As of 10/9/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock MXCT vs. ADV, ABM, RGP, LEAF, NEO, TCY, ACM, PRG, AMFW, and IBEXShould you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include Advance Energy (ADV), African Battery Metals (ABM), Ross Group (RGP), Leaf Clean Energy (LEAF), Neo Energy Metals (NEO), 1619348 (TCY.L) (TCY), 435793 (ACM.L) (ACM), 49379 (PRG.L) (PRG), AMFW.L (AMFW), and IBEX Global Solutions (IBEX). These companies are all part of the "business services" industry. MaxCyte vs. Its Competitors Advance Energy African Battery Metals Ross Group Leaf Clean Energy Neo Energy Metals 1619348 (TCY.L) 435793 (ACM.L) 49379 (PRG.L) AMFW.L IBEX Global Solutions MaxCyte (LON:MXCT) and Advance Energy (LON:ADV) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment. Which has better valuation and earnings, MXCT or ADV? Advance Energy has lower revenue, but higher earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Advance Energy, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaxCyte£35.75M0.05-£45.08M-£0.40-4.05Advance Energy£16K0.00N/A-£0.60N/A Do institutionals and insiders have more ownership in MXCT or ADV? 24.0% of MaxCyte shares are owned by institutional investors. 1.9% of MaxCyte shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is MXCT or ADV more profitable? Advance Energy has a net margin of 0.00% compared to MaxCyte's net margin of -78.37%. Advance Energy's return on equity of 0.00% beat MaxCyte's return on equity.Company Net Margins Return on Equity Return on Assets MaxCyte-78.37% -16.01% -11.07% Advance Energy N/A N/A N/A Does the media prefer MXCT or ADV? In the previous week, Advance Energy had 9 more articles in the media than MaxCyte. MarketBeat recorded 9 mentions for Advance Energy and 0 mentions for MaxCyte. Advance Energy's average media sentiment score of 0.62 beat MaxCyte's score of 0.00 indicating that Advance Energy is being referred to more favorably in the news media. Company Overall Sentiment MaxCyte Neutral Advance Energy Positive SummaryAdvance Energy beats MaxCyte on 6 of the 10 factors compared between the two stocks. Get MaxCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MXCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MXCT vs. The Competition Export to ExcelMetricMaxCyteMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£1.72M£2.57B£6.13B£2.55BDividend YieldN/A2.44%5.72%5.38%P/E Ratio-4.05190.3185.783,663.42Price / Sales0.05131.80612.9299,406.89Price / Cash1.9715.9925.8227.90Price / Book0.013.8312.228.11Net Income-£45.08M£132.05M£3.33B£5.89B7 Day PerformanceN/A2.21%0.67%-0.66%1 Month PerformanceN/A3.68%6.88%0.71%1 Year Performance-99.45%17.68%58.88%129.78% MaxCyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MXCTMaxCyteN/AGBX 1.62flatN/A-99.4%£1.72M£35.75M-4.0580Gap UpHigh Trading VolumeADVAdvance EnergyN/AN/AN/AN/A£2.67M£16K-0.2975,000Gap UpHigh Trading VolumeABMAfrican Battery MetalsN/AN/AN/AN/A£2.00MN/A-0.12127,000Gap DownRGPRoss GroupN/AN/AN/AN/A£1.63M£43K-90.004,260Gap DownLEAFLeaf Clean EnergyN/AN/AN/AN/A£458K-£2M2.80346Gap DownHigh Trading VolumeNEONeo Energy MetalsN/AGBX 0.01flatN/AN/A£150KN/A1.792,100TCY1619348 (TCY.L)N/AN/AN/AN/A£0.00N/A0.004,800ACM435793 (ACM.L)N/AN/AN/AN/A£0.00N/A0.0050,000PRG49379 (PRG.L)N/AN/AN/AN/A£0.00N/A0.001,690High Trading VolumeAMFWAMFW.LN/AN/AN/AN/A£0.00N/A0.0034,013IBEXIBEX Global SolutionsN/AN/AN/AN/A£0.00N/A0.0030,000 Related Companies and Tools Related Companies Advance Energy Competitors African Battery Metals Competitors Ross Group Competitors Leaf Clean Energy Competitors Neo Energy Metals Competitors 1619348 (TCY.L) Competitors 435793 (ACM.L) Competitors 49379 (PRG.L) Competitors AMFW.L Competitors IBEX Global Solutions Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MXCT) was last updated on 10/20/2025 by MarketBeat.com Staff From Our Partners$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBankrupt to billionaire after retirement?Expert Reveals: The #1 Retirement Play for 2025 "We're Entering the Greatest Energy Bull Market Since the I...Brownstone Research | SponsoredTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
